Tag: artificial intelligence

December 3, 2019

CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia

CB2 Insights (CSE:CBII, OTCQB:CBIIF) announced that it is partnering with Licensed Producer FCM Global.
November 27, 2019

Datametrex CEO Discusses Foreign Election Interference With CTV News

Datametrex AI Limited CEO Marshall Gunter spoke with CTV News recently on foreign efforts to influence the Canadian federal election...
November 14, 2019

CB2 Insights to Participate at Piper Jaffray’s 31st Annual Healthcare Conference

CB2 Insights today announced Prad Sekar, CEO of CB2 Insights will be participating in a panel discussion and meeting.
November 8, 2019

CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019, Sequential Growth of 29 Percent

CB2 Insights (CSE:CBII; OTCQB:CBIIF) announces its results for the three and nine months ended September 30, 2019.
November 1, 2019

CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call

CB2 Insights announced preliminary unaudited revenue of approximately $4.2 million for the three months ended September 30, 2019.
October 29, 2019

VIVO and CB2 Insights Enter Technology and Research Partnership

CB2 Insights Inc. announced it has entered into a technology and multi-phase research agreement with VIVO Cannabis Inc.
September 3, 2019

CB2 Insights Announces Appointment of Medical Director in Colombia and Enters Market with Cannabis Research Focus

CB2 Insights (CSE:CBII, OTCQB:CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...